Success Metrics

Clinical Success Rate
90.3%

Based on 28 completed trials

Completion Rate
90%(28/31)
Active Trials
6(11%)
Results Posted
43%(12 trials)
Terminated
3(6%)

Phase Distribution

Ph not_applicable
19
36%
Ph phase_2
8
15%
Ph phase_3
1
2%
Ph phase_1
5
9%

Phase Distribution

5

Early Stage

8

Mid Stage

1

Late Stage

Phase Distribution33 total trials
Phase 1Safety & dosage
5(15.2%)
Phase 2Efficacy & side effects
8(24.2%)
Phase 3Large-scale testing
1(3.0%)
N/ANon-phased studies
19(57.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.3%

28 of 31 finished

Non-Completion Rate

9.7%

3 ended early

Currently Active

6

trials recruiting

Total Trials

53

all time

Status Distribution
Active(11)
Completed(28)
Terminated(3)
Other(11)

Detailed Status

Completed28
unknown11
Recruiting5
Not yet recruiting5
Terminated3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
53
Active
6
Success Rate
90.3%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (15.2%)
Phase 28 (24.2%)
Phase 31 (3.0%)
N/A19 (57.6%)

Trials by Status

recruiting59%
unknown1121%
completed2853%
terminated36%
not_yet_recruiting59%
active_not_recruiting12%

Recent Activity

Clinical Trials (53)

Showing 20 of 53 trialsScroll for more
NCT03388619Phase 1

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

Completed
NCT03745326Phase 1

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

Terminated
NCT06270927

A Feasibility Study for Randomization of Code Stroke Imaging Strategies

Active Not Recruiting
NCT04126161Not Applicable

HIP: Hip Imaging Protocol

Completed
NCT06308094Not Applicable

320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation Before AF Ablation.

Recruiting
NCT06237673Not Applicable

The "CAD-Man" EXTEND Study

Completed
NCT03258593Phase 1

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Completed
NCT06537193Not Applicable

Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment

Recruiting
NCT04294641Phase 2

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Completed
NCT05035407Phase 1

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

Terminated
NCT07183566

CT Volume Measurement of Hepatocellular Carcinoma

Not Yet Recruiting
NCT00924027Phase 2

A Study of Patients Receiving High-Dose Rate Brachytherapy

Completed
NCT05009979Phase 2

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Terminated
NCT00001337Phase 2

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Completed
NCT00001379Phase 2

Treatment and Natural History Study of Lymphomatoid Granulomatosis

Completed
NCT05083728

S-32 PG 242 Short Stem

Completed
NCT06890442

Skull Bon Variations in Patient with Congenital Unilatral Choanal Atresia

Not Yet Recruiting
NCT06696677Not Applicable

Small Intestine Length Measurement Using 3D CT Volumetry and in Vivo Measurement Using Pre-marked Graspers in Revisional Bariatric Surgeries. A Comparative Study

Recruiting
NCT06668233

Neurologocal Symptoms in CHD

Not Yet Recruiting
NCT06597877

CT Temporal Bone Anatomical Variations

Not Yet Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
53